Advertisement

Journal of Genetic Counseling

, Volume 26, Issue 3, pp 480–490 | Cite as

Factors Associated with Interest in Gene-Panel Testing and Risk Communication Preferences in Women from BRCA1/2 Negative Families

  • Kristina G. Flores
  • Laurie E. Steffen
  • Christopher J. McLouth
  • Belinda E. Vicuña
  • Amanda Gammon
  • Wendy Kohlmann
  • Lucretia Vigil
  • Zoneddy R. Dayao
  • Melanie E. Royce
  • Anita Y. Kinney
Original Research

Abstract

Scientific advances have allowed the development of multiplex gene-panels to assess many genes simultaneously in women who have tested negative for BRCA1/2. We examined correlates of interest in testing for genes that confer modest and moderate breast cancer risk and risk communication preferences for women from BRCA negative families. Female first-degree relatives of breast cancer patients who tested negative for BRCA1/2 mutations (N = 149) completed a survey assessing multiplex genetic testing interest and risk communication preferences. Interest in testing was high (70 %) and even higher if results could guide risk-reducing behavior changes such as taking medications (79 %). Participants preferred to receive genomic risk communications from a variety of sources including: primary care physicians (83 %), genetic counselors (78 %), printed materials (71 %) and the web (60 %). Factors that were independently associated with testing interest were: perceived lifetime risk of developing cancer (odds ratio (OR) = 1.67: 95 % confidence interval (CI) 1.06–2.65) and high cancer worry (OR = 3.12: CI 1.28–7.60). Findings suggest that women from BRCA1/2 negative families are a unique population and may be primed for behavior change. Findings also provide guidance for clinicians who can help develop genomic risk communications, promote informed decision making and customize behavioral interventions.

Keywords

Gene-panel Genetic testing BRCA1/2 negative Hereditary breast cancer Informed decision-making 

Notes

Acknowledgments

We would like to thank the REACH Project participants and their relatives, who made this research possible. This work was supported by grants from the National Cancer Institute at the National Institutes of Health (1R01CA129142 to AYK and U01 CA152958) and the UNM Comprehensive Cancer Center P30 (P30CA118100). The project was also supported by the Shared Resources (P30 CA042014) at Huntsman Cancer Institute (Biostatistics and Research Design, Genetic Counseling, Research Informatics, and the Utah Population Database [UPDB]); the Utah Cancer Registry, which is funded by Contract No.HHSN261201000026C from the National Cancer Institute’s Surveillance, Epidemiology and End Results (SEER) Program with additional support from the Utah State Department of Health and the University of Utah; the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant 8UL1TR000105 (formerly UL1RR025764). This content is solely the responsibility of the authors and does not necessarily reflect the opinions or views of the funding and supporting agencies.

Compliance with Ethical Standards

Conflict of Interest

Authors Kristina Flores, Laurie Steffen, Christopher McLouth, Belinda Vicuna, Amanda Gammon, Lucretia Vigil, Zoneddy Dayao, Melanie Royce, and Anita Kinney have no conflict of interest.

Wendy Kohlmann received compensation within the past three years for consultation to Myriad Genetics.

Human Studies and Informed Consent

All procedures followed were in accordance with the ethical standards of University of Utah on human experimentation and with the 1964 Helsinki declaration and it later amendments or comparable ethical standards. Informed consent was obtained from all participants included in the study.

Animal Studies

No animal studies were carried out by the authors for this article.

References

  1. Anderson, A. E., Flores, K. G., Boonyasiriwat, W., Gammon, A., Kohlmann, W., Birmingham, W. C., & Kinney, A. Y. (2014). Interest and informational preferences regarding genomic testing for modest increases in colorectal cancer risk. Public Health Genomics, 17(1), 48–60.CrossRefPubMedPubMedCentralGoogle Scholar
  2. Bottorff, J. L., Ratner, P. A., Balneaves, L. G., Richardson, C. G., McCullum, M., Hack, T., & Buxton, J. (2002). Women's interest in genetic testing for breast cancer risk: the influence of sociodemographics and knowledge. Cancer Epidemiology, Biomarkers & Prevention, 11(1), 89–95.Google Scholar
  3. Bradbury, A. R., Patrick-Miller, L., & Domchek, S. (2015a). Multiplex genetic testing: reconsidering utility and informed consent in the era of next-generation sequencing. Genetics in Medicine, 17(2), 97–98.CrossRefPubMedGoogle Scholar
  4. Bradbury, A. R., Patrick-Miller, L. J., Egleston, B. L., DiGiovanni, L., Brower, J., Harris, D., & Domchek, S. M. (2015b). Patient feedback and early outcome data with a novel tiered-binned model for multiplex breast cancer susceptibility testing. Genetics in Medicine, 18(1), 25–33.CrossRefPubMedGoogle Scholar
  5. Cameron, L. D., & Diefenbach, M. A. (2001). Responses to information about psychosocial consequences of genetic testing for breast cancer susceptibility: influences of cancer worry and risk perceptions. Journal of Health Psychology, 6(1), 47–59.CrossRefPubMedGoogle Scholar
  6. Cameron, L. D., & Muller, C. (2009). Psychosocial aspects of genetic testing. Current Opinion in Psychiatry, 22(2), 218–223.CrossRefPubMedGoogle Scholar
  7. Cameron, L. D., & Reeve, J. (2006). Risk perceptions, worry, and attitudes about genetic testing for breast cancer susceptibility. Psychology & Health, 21(2), 211–230.CrossRefGoogle Scholar
  8. Codori, A. M., Petersen, G. M., Miglioretti, D. L., Larkin, E. K., Bushey, M. T., Young, C., & Booker, S. V. (1999). Attitudes toward colon cancer gene testing: factors predicting test uptake. Cancer Epidemiology, Biomarkers & Prevention, 8(4 Pt 2), 345–351.Google Scholar
  9. Cohn, J., Blazey, W., Tegay, D., Harper, B., Koehler, S., Laurent, B., Krishnamachari, B. (2015). Physician risk assessment knowledge regarding BRCA Genetics Testing. Journal of Cancer Education, 30(3), 573–579.CrossRefPubMedGoogle Scholar
  10. Collins, F. S., & Varmus, H. (2015). A new initiative on precision medicine. The New England Journal of Medicine, 372(9), 793–795.CrossRefPubMedPubMedCentralGoogle Scholar
  11. Cragun, D., Bonner, D., Kim, J., Akbari, M. R., Narod, S. A., Gomez-Fuego, A., & Pal, T. (2015). Factors associated with genetic counseling and BRCA testing in a population-based sample of young black women with breast cancer. Breast Cancer Research and Treatment, 151(1), 169–176.CrossRefPubMedPubMedCentralGoogle Scholar
  12. Croyle, R. T., & Lerman, C. (1993). Interest in genetic testing for colon cancer susceptibility: cognitive and emotional correlates. Preventive Medicine, 22(2), 284–292.CrossRefPubMedGoogle Scholar
  13. Daly, M. B., Pilarski, R., Axilbund, J. E., Berry, M., Buys, S. S., Crawford, B., & Darlow, S. (2016). Genetic/familial high-risk assessment: breast and ovarian, Version 2.2015. Journal of the National Comprehensive Cancer Network, 14(2), 153–162.CrossRefPubMedGoogle Scholar
  14. Desmond, A., Kurian, A. W., Gabree, M., Mills, M. A., Anderson, M. J., Kobayashi, Y., & Ellisen, L. W. (2015). Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment. JAMA Oncol, 1(7), 943–951.CrossRefPubMedGoogle Scholar
  15. Easton, D. F., Pharoah, P. D., Antoniou, A. C., Tischkowitz, M., Tavtigian, S. V., Nathanson, K. L., & Foulkes, W. D. (2015). Gene-panel sequencing and the prediction of breast-cancer risk. The New England Journal of Medicine, 372(23), 2243–2257.CrossRefPubMedPubMedCentralGoogle Scholar
  16. Evans, D. G., Warwick, J., Astley, S. M., Stavrinos, P., Sahin, S., Ingham, S., & Howell, A. (2012). Assessing individual breast cancer risk within the U.K. National Health Service Breast Screening Program: a new paradigm for cancer prevention. Cancer Prevention Research (Philadelphia, Pa.), 5(7), 943–951.CrossRefGoogle Scholar
  17. Evans, D. G., Barwell, J., Eccles, D. M., Collins, A., Izatt, L., Jacobs, C., Murray, A. (2014). The Angelina Jolie effect: how high celebrity profile can have a major impact on provision of cancer related services. Breast Cancer Research, 16(5), 442.Google Scholar
  18. Gibbons, A., & Groarke, A. (2015). Can risk and illness perceptions predict breast cancer worry in healthy women? J Health Psychol. doi: 10.1177/1359105315570984.Google Scholar
  19. Graves, K. D., Wenzel, L., Schwartz, M. D., Luta, G., Wileyto, P., Narod, S., & Halbert, C. H. (2010). Randomized controlled trial of a psychosocial telephone counseling intervention in BRCA1 and BRCA2 mutation carriers. Cancer Epidemiology, Biomarkers & Prevention, 19(3), 648–654.CrossRefGoogle Scholar
  20. Graves, K. D., Peshkin, B. N., Luta, G., Tuong, W., & Schwartz, M. D. (2011). Interest in genetic testing for modest changes in breast cancer risk: implications for SNP testing. Public Health Genomics, 14(3), 178–189.CrossRefPubMedPubMedCentralGoogle Scholar
  21. Henneman, L., Vermeulen, E., van El, C. G., Claassen, L., Timmermans, D. R., & Cornel, M. C. (2013). Public attitudes towards genetic testing revisited: comparing opinions between 2002 and 2010. European Journal of Human Genetics, 21(8), 793–799.CrossRefPubMedGoogle Scholar
  22. Himes, D. O., Clayton, M. F., Donaldson, G. W., Ellington, L., Buys, S. S., & Kinney, A. Y. (2016). Breast cancer risk perceptions among relatives of women with uninformative negative BRCA1/2 test results: the moderating effect of the amount of shared information. Journal of Genetic Counseling, 25(2), 258–269.Google Scholar
  23. Hoberg-Vetti, H., Bjorvatn, C., Fiane, B. E., Aas, T., Woie, K., Espelid, H., & Hoogerbrugge, N. (2016). BRCA1/2 testing in newly diagnosed breast and ovarian cancer patients without prior genetic counselling: the DNA-BONus study. European Journal of Human Genetics, 24(6), 881–888.CrossRefPubMedGoogle Scholar
  24. IPAQ. (2015) International Physical Activity Questionnaire. WWW.ipaq.ki.se. Accessed March 3, 2015.Google Scholar
  25. Jensen, J. D., Bernat, J. K., Davis, L. A., & Yale, R. (2010). Dispositional cancer worry: convergent, divergent, and predictive validity of existing scales. Journal of Psychosocial Oncology, 28(5), 470–489.CrossRefPubMedPubMedCentralGoogle Scholar
  26. Kabat, G. C., Matthews, C. E., Kamensky, V., Hollenbeck, A. R., & Rohan, T. E. (2015). Adherence to cancer prevention guidelines and cancer incidence, cancer mortality, and total mortality: a prospective cohort study. The American Journal of Clinical Nutrition, 101(3), 558–569.CrossRefPubMedPubMedCentralGoogle Scholar
  27. Kelly, K. M., Andrews, J. E., Case, D. O., Allard, S. L., & Johnson, J. D. (2007). Information seeking and intentions to have genetic testing for hereditary cancers in rural and Appalachian Kentuckians. The Journal of Rural Health, 23(2), 166–172.CrossRefPubMedGoogle Scholar
  28. Kinney, A. Y., Butler, K. M., Schwartz, M. D., Mandelblatt, J. S., Boucher, K. M., Pappas, L. M., & Campo, R. A. (2014). Expanding access to BRCA1/2 genetic counseling with telephone delivery: a cluster randomized trial. Journal of the National Cancer Institute, 106(12). doi: 10.1093/jnci/dju328.
  29. Kotsopoulos, J., Metcalfe, K., Alston, J., Nikitina, D., Ginsburg, O., Eisen, A., & Narod, S. A. (2014). Prospective study of high-risk, BRCA1/2-mutation negative women: the 'negative study. BMC Cancer, 14, 221.CrossRefPubMedPubMedCentralGoogle Scholar
  30. Lebo, P. B., Quehenberger, F., Kamolz, L. P., & Lumenta, D. B. (2015). The Angelina effect revisited: exploring a media-related impact on public awareness. Cancer, 121(22), 3959–3964.CrossRefPubMedGoogle Scholar
  31. Lerman, C., Daly, M., Masny, A., & Balshem, A. (1994). Attitudes about genetic testing for breast-ovarian cancer susceptibility. Journal of Clinical Oncology, 12(4), 843–850.CrossRefPubMedGoogle Scholar
  32. Li, H., Feng, B., Miron, A., Chen, X., Beesley, J., Bimeh, E., & Goldgar, D. E. (2016). Breast cancer risk prediction using a polygenic risk score in the familial setting: a prospective study from the breast cancer family registry and kConFab. Genetics in Medicine. doi: 10.1038/gim.2016.43.Google Scholar
  33. Lincoln, S. E., Kobayashi, Y., Anderson, M. J., Yang, S., Desmond, A. J., Mills, M. A.,. Ellisen, L. W. (2015). A systematic comparison of traditional and Multigene panel testing for hereditary breast and ovarian cancer genes in more than 1000 patients. The Journal of Molecular Diagnostics, 17(5), 533–544.CrossRefPubMedGoogle Scholar
  34. Lipkus, I. M., Kuchibhatla, M., McBride, C. M., Bosworth, H. B., Pollak, K. I., Siegler, I. C., & Rimer, B. K. (2000). Relationships among breast cancer perceived absolute risk, comparative risk, and worries. Cancer Epidemiology, Biomarkers & Prevention, 9(9), 973–975.Google Scholar
  35. Markossian, T. W., & Hines, R. B. (2012). Disparities in late stage diagnosis, treatment, and breast cancer-related death by race, age, and rural residence among women in Georgia. Women & Health, 52(4), 317–335.CrossRefGoogle Scholar
  36. Mavaddat, N., Pharoah, P. D., Michailidou, K., Tyrer, J., Brook, M. N., Bolla, M. K., & Garcia-Closas, M. (2015). Prediction of breast cancer risk based on profiling with common genetic variants. Journal of the National Cancer Institute, 107(5).Google Scholar
  37. McBride, C. M., Birmingham, W. C., & Kinney, A. Y. (2015). Health psychology and translational genomic research: Bringing innovation to cancer-related behavioral interventions. The American Psychologist, 70(2), 91–104.CrossRefPubMedGoogle Scholar
  38. McCarthy, A. M., Bristol, M., Fredricks, T., Wilkins, L., Roelfsema, I., Liao, K., & Armstrong, K. (2013). Are physician recommendations for BRCA1/2 testing in patients with breast cancer appropriate? A population-based study. Cancer, 119(20), 3596–3603.CrossRefPubMedPubMedCentralGoogle Scholar
  39. McCaul, K. D., & Goetz, P. W. Worry. (2015) A paper on the National Cancer Institute website http://cancercontrol.cancer.gov/Brp/constructs/worry/worry.pdf Accessed March 30, 2015.
  40. McGuire, A. L., Diaz, C. M., Wang, T., & Hilsenbeck, S. G. (2009). Social networkers' attitudes toward direct-to-consumer personal genome testing. The American Journal of Bioethics, 9(6–7), 3–10.CrossRefPubMedPubMedCentralGoogle Scholar
  41. Meisel, S. F., Carere, D. A., Wardle, J., Kalia, S. S., Moreno, T. A., Mountain, J. L., & Group, P. G. S (2015). Explaining, not just predicting, drives interest in personal genomics. Genome Medicine, 7(1), 74.CrossRefPubMedPubMedCentralGoogle Scholar
  42. Milhabet, I., Duprez, C., Krzeminski, A., & Christophe, V. (2013). Cancer risk comparative perception and overscreening behaviours of non-carriers from BRCA1/2 families. European Journal of Cancer Care (Engl), 22(4), 540–548.CrossRefGoogle Scholar
  43. Moyer, V. A., & Force, U. S. P. S. T. (2013). Medications to decrease the risk for breast cancer in women: recommendations from the U.S. Preventive Services Task Force recommendation statement. Annals of Internal Medicine, 159(10), 698–708.PubMedGoogle Scholar
  44. Nelson, H. D., Smith, M. E., Griffin, J. C., & Fu, R. (2013). Use of medications to reduce risk for primary breast cancer: a systematic review for the U.S. Preventive Services Task Force. Annals of Internal Medicine, 158(8), 604–614.CrossRefPubMedGoogle Scholar
  45. Nguyen-Pham, S., Leung, J., & McLaughlin, D. (2014). Disparities in breast cancer stage at diagnosis in urban and rural adult women: a systematic review and meta-analysis. Annals of Epidemiology, 24(3), 228–235.CrossRefPubMedGoogle Scholar
  46. Patenaude, A. F., Dorval, M., DiGianni, L. S., Schneider, K. A., Chittenden, A., & Garber, J. E. (2006). Sharing BRCA1/2 test results with first-degree relatives: factors predicting who women tell. Journal of Clinical Oncology, 24(4), 700–706.CrossRefPubMedGoogle Scholar
  47. Petersen, K. E., Johnsen, N. F., Olsen, A., Albieri, V., Olsen, L. K., Dragsted, L. O., & Egeberg, R. (2015). The combined impact of adherence to five lifestyle factors on all-cause, cancer and cardiovascular mortality: a prospective cohort study among Danish men and women. The British Journal of Nutrition, 113(5), 849–858.CrossRefPubMedGoogle Scholar
  48. Powell, K. P., Cogswell, W. A., Christianson, C. A., Dave, G., Verma, A., Eubanks, S., & Henrich, V. C. (2012). Primary care physicians' awareness, experience and opinions of direct-to-consumer genetic testing. Journal of Genetic Counseling, 21(1), 113–126.CrossRefPubMedGoogle Scholar
  49. Powers, J., & Stopfer, J. E. (2014). Risk assessment, genetic counseling, and clinical care for hereditary breast cancer. Journal of Obstetric, Gynecologic, and Neonatal Nursing, 43(3), 361–373.CrossRefPubMedGoogle Scholar
  50. Ramirez, A. G., Chalela, P., Gallion, K. J., Munoz, E., Holden, A. E., Burhansstipanov, L., Suarez, L. (2015). Attitudes Toward Breast Cancer Genetic Testing in Five Special Population Groups J Health Dispar Res Pract, 8(4), 124–135.Google Scholar
  51. Roberts, J. S., & Ostergren, J. (2013). Direct-to-Consumer Genetic Testing and Personal Genomics Services: A Review of Recent Empirical Studies. Curr Genet Med Rep, 1(3), 182–200.CrossRefPubMedPubMedCentralGoogle Scholar
  52. Selkirk, C. G., Vogel, K. J., Newlin, A. C., Weissman, S. M., Weiss, S. M., Wang, C. H., & Hulick, P. J. (2014). Cancer genetic testing panels for inherited cancer susceptibility: the clinical experience of a large adult genetics practice. Familial Cancer, 13(4), 527–536.CrossRefPubMedGoogle Scholar
  53. Sussner, K. M., Edwards, T. A., Thompson, H. S., Jandorf, L., Kwate, N. O., Forman, A., & Valdimarsdottir, H. B. (2011). Ethnic, racial and cultural identity and perceived benefits and barriers related to genetic testing for breast cancer among at-risk women of African descent in New York City. Public Health Genomics, 14(6), 356–370.CrossRefPubMedPubMedCentralGoogle Scholar
  54. Teng, I., & Spigelman, A. (2014). Attitudes and knowledge of medical practitioners to hereditary cancer clinics and cancer genetic testing. Familial Cancer, 13(2), 311–324.CrossRefPubMedGoogle Scholar
  55. Trivers, K. F., Baldwin, L. M., Miller, J. W., Matthews, B., Andrilla, C. H., Lishner, D. M., & Goff, B. A. (2011). Reported referral for genetic counseling or BRCA 1/2 testing among United States physicians: a vignette-based study. Cancer, 117(23), 5334–5343.CrossRefPubMedGoogle Scholar
  56. US Department of Agriculture. (2015) Dietary Guidelines for Americans. http://www.health.gov/dietaryguidelines/. Retrieved July 6, 2015.
  57. Vermeulen, E., Henneman, L., van El, C. G., & Cornel, M. C. (2014). Public attitudes towards preventive genomics and personal interest in genetic testing to prevent disease: a survey study. European Journal of Public Health, 24(5), 768–775.CrossRefPubMedGoogle Scholar
  58. Weinrich, S., Royal, C., Pettaway, C. A., Dunston, G., Faison-Smith, L., Priest, J. H., & Powell, I. (2002). Interest in genetic prostate cancer susceptibility testing among african American men. Cancer Nursing, 25(1), 28–34.CrossRefPubMedGoogle Scholar
  59. Wolfe Schneider, K., Anguiano, A., Axell, L., Barth, C., Crow, K., Gilstrap, M., & Freivogel, M. (2014). Collaboration of Colorado cancer genetic counselors to integrate next generation sequencing panels into clinical practice. Journal of Genetic Counseling, 23(4), 640–646.CrossRefPubMedGoogle Scholar

Copyright information

© National Society of Genetic Counselors, Inc. 2016

Authors and Affiliations

  • Kristina G. Flores
    • 1
  • Laurie E. Steffen
    • 1
    • 2
  • Christopher J. McLouth
    • 2
  • Belinda E. Vicuña
    • 1
    • 2
  • Amanda Gammon
    • 3
  • Wendy Kohlmann
    • 3
  • Lucretia Vigil
    • 1
  • Zoneddy R. Dayao
    • 1
    • 4
  • Melanie E. Royce
    • 1
    • 4
  • Anita Y. Kinney
    • 1
    • 4
  1. 1.University of New Mexico Comprehensive Cancer Center, University of New MexicoAlbuquerqueUSA
  2. 2.Department of PsychologyUniversity of New MexicoAlbuquerqueUSA
  3. 3.Huntsman Cancer InstituteUniversity of UtahSalt Lake CityUSA
  4. 4.Department of Internal MedicineUniversity of New MexicoAlbuquerqueUSA

Personalised recommendations